Microbot Medical Expands Telesurgery Collaboration with Corewell
Microbot Medical Expands Collaboration with Corewell Health
Microbot Medical Inc. (NASDAQ: MBOT), a pioneer in innovative medical technologies, has announced a significant Phase 2 collaboration agreement with Corewell Health. This initiative builds on the successful outcomes from Phase 1, which assessed the viability of the LIBERTY Endovascular Robotic System as an efficient platform for remote telesurgery.
Objectives of Phase 2
The primary goal of Phase 2 is to further develop and demonstrate advanced telesurgery capabilities through simulated interventional procedures executed across two facilities within the Corewell Health system. These sites are strategically positioned only 5 miles apart, facilitating effective evaluation and testing of the LIBERTY system's remote functionalities.
Significant Developments from Phase 1
The initial phase of collaboration highlighted the technical success and potential applications for LIBERTY in various endovascular interventions. This phase confirmed LIBERTY's capacity to support remote telesurgery, paving the way for innovative approaches in cardiovascular care.
Leadership and Research Contributions
The collaboration is spearheaded by Dr. Ryan Madder, a seasoned expert in interventional cardiology and currently the Section Chief at Corewell Health's Cardiac Cath Lab. Following the completion of Phase 1, Dr. Madder and his team contributed to the field through their publication in a leading cardiology journal, emphasizing the advanced techniques utilized in coronary guidewire and stent delivery.
Future of Remote Telesurgery
CEO of Microbot Medical, Harel Gadot, expressed optimism regarding the project, stating, "Incorporating telesurgery capabilities is a vital aspect of our strategic vision for LIBERTY. We believe that the need for increased access to medical care, especially in remote areas, aligns with our objectives, and we are eager to push forward with Corewell Health and Dr. Madder on this next frontier of development." This sentiment reflects the company’s commitment to revolutionizing access to surgical care.
The LIBERTY Endovascular Robotic System
The LIBERTY Endovascular Robotic Surgical System aims to transform surgical practices by minimizing traditional requirements for large surgical equipment, which often hinder accessibility and increase radiation exposure for medical professionals. This innovative approach can offer significant advantages in terms of patient care and operational efficiency.
About Microbot Medical Inc.
Microbot Medical is a clinical-stage medical device company dedicated to developing groundbreaking micro-robotic technologies. These advancements are aimed at improving patient outcomes and enhancing accessibility by navigating the natural and artificial lumens within the human body.
Commitment to Innovation
The company's vision includes making remote operations a feasible option for endovascular procedures, potentially democratizing access to advanced surgical techniques for patients worldwide. As they continue to progress with the LIBERTY system, the expectation is to redefine how surgeries are performed, thus aligning with their mission to innovate within the medical field.
Frequently Asked Questions
What is the LIBERTY Endovascular Robotic System?
The LIBERTY Endovascular Robotic System is an innovative robotic technology designed to enhance remote surgical procedures, particularly in endovascular interventions.
What are the goals of the Phase 2 collaboration?
Phase 2 aims to further develop and demonstrate telesurgery capabilities through simulated procedures at different sites within Corewell Health.
Who is leading the project?
Dr. Ryan Madder, the Section Chief of Interventional Cardiology at Corewell Health, is leading the collaboration project.
How does LIBERTY improve surgical access?
LIBERTY reduces the need for bulky surgical equipment, minimizes radiation exposure, and addresses the challenges associated with administering care in remote environments.
What is Microbot Medical's vision?
Microbot Medical aims to transform surgical practices through innovative technologies that enhance accessibility to life-saving procedures, particularly for patients in underserved areas.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.